Does activated neutrophil depletion on bypass by leukocyte filtration reduce myocardial damage? A preliminary report

Journal of Cardiovascular Surgery

Volumn 37, Issue 6 SUPPL. 1, 1996, Pages 93-100

  Di Salvo, C ^a   Louca, L L ^a   Pattichis, K ^a   Hooper, J ^a   Walesby, R K ^a,b  

^a QUEEN CHARLOTTE S AND CHELSEA HOSPITAL   (United Kingdom)

^b Harley Street Clinic Consulting Rooms ^*  (United Kingdom)

Author keywords

Cardiopulmonary bypass; Myocardial damage; Neutrophils

Indexed keywords

CREATINE KINASE; GLUTATHIONE; ISOENZYME; TROPONIN T;

AGED; ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; EXTRACORPOREAL CIRCULATION; FEMALE; FILTRATION; HUMAN; INSTRUMENTATION; LEUKAPHERESIS; LEUKOCYTE; LEUKOCYTE ACTIVATION; MALE; NEUTROPHIL; PHYSIOLOGY; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; REPERFUSION INJURY; UNSTABLE ANGINA PECTORIS;

AGED; ANGINA, UNSTABLE; CORONARY ARTERY BYPASS; CREATINE KINASE; EXTRACORPOREAL CIRCULATION; FEMALE; FILTRATION; GLUTATHIONE; HUMANS; ISOENZYMES; LEUKAPHERESIS; LEUKOCYTES; MALE; MYOCARDIAL REPERFUSION INJURY; NEUTROPHIL ACTIVATION; NEUTROPHILS; PILOT PROJECTS; TROPONIN T;

EID: 0030308167     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Nayeler WG, Elz JS. Reperfusion injury: laboratory artifact or clinical dilemma? Circulation 1986;74:215-21.
2. Kloner KA. Do neutrophils mediate the phenomenon of stunned myocardium? J Am Coll Cardiol 1989;13:1164-6.
3. Lucchesi BR, Mullane KM. Leukocytes and ischemia-induced myocardial injury. Ann Rev Pharmacol Toxicol 1986;26:201-24.
4. Wilson K, Hawes AS, Lazenby WD et al. Myocardial reperfusion injury platelet-activating factor stimulates polymorphonuclear leukocyte hydrogen peroxide production during myocardial reperfusion. J Thorac Cardiovasc Surg 1991;102:297-308.
5. Romnson JL, Hook BB, Hunkel SL, Abrams GD, Schork MA, Lucchesi BR. Reduction of the extent of ischemic reperfusion injury by neutrofil depletion in the dog. Circulation 1983; 67:1016-23.
6. Curello C, Ceconi C, Cargnoni A et al. Improved procedure for determining glutathione in plasma as an index of myocardial oxidative stress. Clin Chem 1987;33:1448-9.
7. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidised glutathione: applications to mammalian blood and other tissues. Anal Biochem 1969;27:502-22.
8. Metha J, Nichols W, Metha P. Neutrophils as potential participants in acute myocardial ischemia: relevance to reperfusion. J Am Coll Cardiol 1988;1309-16.
9. Engler R, Covell JW. Granulocytes cause reperfusion ventricular dysfunction after 15-minute ischemia in the dog. Circ Res 1987;61:20-8.
10. Engler RL, Dahlgren MD, Morris DD, Peterson MA, Schmid-Schoenbein GW. Role of leukocytes in response to acute myocardial ischemia and reflow in dogs. Am J Physiol 1986;251(2 Pt2):H314-23.
11. Kloner RA, Ganote CE, Jennings RB. The «no-reflow» phenomenon after temporary coronary occlusion in the dog. J Clin Invest 1974;54:1496-508.
12. Schmid-Schonbein GW. Capillary plugging by granulocytes and the no-reflow phenomenon in the microcirculation. Fed Proc 1987;15:46:2397-401.
13. Lucchesi BR. Myocardial ischemia, reperfusion and free radical injury. Am J Cardiol 1990;65:141-231.
14. Westlin W, Mullane KM. Alleviation of myocardial stunning by leukocyte and platelet depletion. Circulation 1989;80: 1828-36.
15. Tabayashi K, Suzuki Y, Nagamine S, Ho Y, Sekino Y, Mohri H. A clinical trial of allopurinol (Zyloric) for myocardial protection. J Thorac Cardiovasc Surg 1991;101:713-8.
16. Shlafer M, Kane PF, Wiggins VY, Kirsh MM. Possible role for cytotoxic oxygen metabolites in the pathogenesis of cardiac ischemic injury. Circulation 1982;66(1):185-92.
17. Menasche P, Grousset C, Gaudel Y, Mouas C, Piwnica A. Enhancement of cardioplegic protection with the free-radical scavenger peroxidase. Circulation 1986;74:III138-43.
18. Friclovich I. Superoxide Dismutases. Ann Rev Biochem 1975; 44:147.
19. Moorhouse PC, Grootveld M, Halliwell B, Ouinlan JC, Gutteridge JMC. Allopurinol and oxypurinol are hydroxyl radical scavengers. FEBS Lett 1987;213:23-8.
20. Myers CL, Weiss SJ, Kirsh MM, Shepard BM, Shlafer M. Effects of supplementing hypotherimic crystalloid cardioplegic solution with catalase, superoxide dismutase, allopurinol, or deferomanine on functional recovery of globally ischemic and reperfused isolated hearts. J Thorac Cardiovasc Surg 1987;91:281-9.
21. Puett DW, Forman MB, Cates CU et al. Oxypurinol limits myocardial stunning but does not reduce infarct size after reperfusion. Circulation 1987;76:678-86.
22. Taggart DP, Young V, Hooper J, Walesby RK. Lack of cardioprotective efficacy of allopurinol in coronary artery surgery. Br Heart J 1994;71:177-81.
23. Wachtfogel YT, Kucich U, Greenplate J et al. Human neutrofil degranulation during extracorporeal circulation. Blood 1987; 69:324-30.
24. Kazuyoshy T, Fumio Y, Kohei K et al. Cardiopulmonary bypass and cellular immunity: Changes in lymphocyte subsets and natural killer cell activity. Ann Thorac Surg 1993;55:625-30.
25. Jensen LS, Andersen AJ, Christiansen PM et al. Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg 1992;79:513-6.
26. Ferrari R, Ceconi C, Curello S, Cargnoni A, Condorelli E, Bellili S et al. Metabolic changes during post-ischaemic reperfusion. Mol Cell Cardiol 1988;20:119-32.
27. Ceconi C, Curello S, Cargnoni A, Ferrari R, Albertini A, Visioli O. The role of glutathione status in the protection against ischaemic and reperfusion damage: effects of N-acetyl cysteine; J Mol Cell Cardiol 1988;20:5-12.
28. Brigelius R, Muckel C, Akerboom TPM, Sies H. Identification and quantitiation of glutathione in hepatic protein mixed disulphides and its relationship to glutathione disulphide. Biochem Pharmacol 1983;32:2529-34.
29. Magnani M, Novelli G, Palloni R. Human plasma gluatathione oxidation in normal and pathological conditions. Clin Physiol Biochem 1984;2:287-90.
30. Ferrari R, Ceconi C, Curello S et al. Role of oxygen free radicals in ischemic and reperfused myocardium. Am J Clin Nutr 1991;53:15S-22S.
31. Curello S, Ceconi C, Medici D, Ferrari R. Oxidative stress during myocardial ischemia and reperfusion: experimental and clinical evidences. J Appl Cardiol 1986;1:311-27.
32. Curello S, Cecconi C, Bigoli C et al. Change in the cardiac glutathione status after ischemia and reperfusion. Experientia 1985;41:42-3.
33. Katus HA, Remppis A, Neumann FJ et al. Diagnostic efficiency of troponin T measurements in acute myocardial infarction. Circulation 1991.83:902-12.
34. Gerhardt W, Katus HA, Ravkilde J et al. S-troponin T in suspected ischemic myocardial injury compared with mass and catalytic concentrations of S-creatine kinase isoenzyme MB. Clin Chem 1991;37:1405-11.
35. Mair J, Wieser C, Seibt I et al. Tropinin T to diagnose myocardial infarciton in bypass surgery. Lancet 1991;337:434-5.
36. Katus HA, Remppis A, Scheffold T et al. Intracellular comparmentation of cardiac troponin T and its release kinetics inpatients with reperfused and non reperfused myocardial infarction. Am J Cardiol 1991;67:1361-7.
37. Mair J, Artner-Dworzak E, Lechleitner P et al. Cardiac troponin T in diagnosis of acute myocardial infarction. Clin Chem 1991;37:845-52.
38. Katus HA, Scheppenthau M, Tanzeem A et al. Non-invasive assessment of the perioperative myocardial cell damage by circulating cyardiac troponin T. Br Heart J 1991;65:259-64.
39. Seguin J, Saussine M, Ferriere M et al. Comparison of myoglobin and creatine kinase MB levels in the evaluation of myocardial injury after cardiac operation. J Thorac Cardiovasc Surg 1988;95:294-7.